CD93 and cancer: The HALLMARK enrichment term showed that CD93 expression was positively associated with the process of promoting cancers and inflammation, including interferon gamma response, inflammatory response, TNF signaling via NF-κB, complements, angiogenesis, EMT, IL-2-STAT5 signaling, kras signaling up, myc targets V2, and hedgehog signaling, in almost all cancers we analyzed.